• Vibalogics Establishes U.S. Presence contractpharma
    November 17, 2020
    Vibalogics, a global contract development and manufacturing organization (CDMO), has initiated Phase I of its planned $150 million investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, MA.
PharmaSources Customer Service